Oncology Clinical Trial Finder

Breast Cancer

Recruiting • Phase O • Stage 0, I, II, III, IV • Post-Menopausal • Interventional

The following is imported from ClinicalTrials.gov:

3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer

This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating axillary lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.

PRIMARY OBJECTIVES: I. Conducting a pilot study to optimize the in vivo performance of the newly developed three-dimensional (3D)-ultrasound (US) technology. II. Evaluate the performance of the new 3D-US technique in differentiating benign from malignant axillary lymph nodes (ALNs). III. Compare the performance of the new 3D-US method with conventional two-dimensional (2D)-US for localizing the clipped ALNs. OUTLINE: Patients undergo 3D-US on study. Patients who have an ALN clip placed and undergoing neoadjuvant chemotherapy undergo imaging of the clipped node before surgery.

Breast Cancer

Study Design

Study type:


Estimated enrollment:

60 participant

Actual study start date:

February 14, 2023

Eligibility Criteria

Ages eligible for study:

18 - 999

Sexes eligible for study:


Arms and Intervention

  • Ultrasound Imaging

Inclusion criteria

  • female patients with breast cancer and scheduled to have axillary lymph node biopsy as per routine clinical care.

  • age of 18 or older.

Exclusion criteria

  • vulnerable subjects such as prisoners and adults lacking capacity to consent.

Trial Information at Site

Last Updated:

Trial Information

ClinicalTrial.gov ID:


Estimated Enrollment:


Last Updated:


Site Contact

Clinical Trials Referral Office



Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Principal Investigator

Shigao D Chen

Trial Sponsor

Mayo Clinic

Study Location (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States


© 2023 Outcomes4Me Inc. All rights reserved.